A change of therapeutic focus, a full rebrand and a major cash injection will shake things up considerably at Massachusetts, USA-based Cullinan Therapeutics. 17 April 2024
USA-based Nectero Medical has raised $96 million in a series D financing round led by Norwest Venture Partners, with significant investments also from Boston Sc 12 April 2024
Los Angeles-based TORL BioTherapeutics, a biotech focused on discovering and developing antibody-based immunotherapies, has closed an oversubscribed $158 millio 10 April 2024
A private share placement is set to land Massachusetts, USA-based Acrivon Therapeutics with an additional $130 million to fund its oncology research. 10 April 2024
Seaport Therapeutics has become the latest founded entity to be created by PureTech Health, the UK biotech behind Karuna Therapeutics, which was recently acquir 9 April 2024
British life sciences investor Medicxi is betting $40 million on a Shanghai-based biotech, D3 Bio, working in the areas of oncology and immunology. 8 April 2024
Oruka Therapeutics, a US biotech focused on developing biologics designed to set a new standard for the treatment of chronic skin diseases, including plaque pso 3 April 2024
A start-up focused on neurology, Neurosterix, has launched with a $63 million series A financing led by Perceptive Xontogeny Venture Fund II. 3 April 2024
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.